Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers - Test2 - elhamkhani - TriplyDB

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

http://www.wikidata.org/entity/Q24605342

about

Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer Epigenetic modifications in cancer Lysine glutarylation is a protein posttranslational modification regulated by SIRT5 An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1 VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities HIstome--a relational knowledgebase of human histone proteins and histone modifying enzymes The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences The Impact of External Factors on the Epigenome: In Utero and over Lifetime Post-Translational Modifications of Histones in Vertebrate Neurogenesis Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia SGF29 and Sry pathway in hepatocarcinogenesis Epigenetic Regulation of Carotid Body Oxygen Sensing: Clinical Implications Synthesis of lysine methyltransferase inhibitors PRC2 during vertebrate organogenesis: a complex in transition Linking epithelial-to-mesenchymal-transition and epigenetic modifications Serine, glycine and one-carbon units: cancer metabolism in full circle Chemical probes of histone lysine methyltransferases Cytosine modifications in neurodevelopment and diseases The epigenetic basis of diffuse large B-cell lymphoma Mechanisms of epigenetic regulation of leukemia onset and progression New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells Epigenetics advancing personalized nanomedicine in cancer therapy Genomic impact of cigarette smoke, with application to three smoking-related diseases Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 Demethylation High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylases A novel 3-methylhistidine modification of yeast ribosomal protein Rpl3 is dependent upon the YIL110W methyltransferase.Histone demethylase lysine demethylase 5B in development and cancer Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

P2860

Q22001096-7FB47346-F2DF-49F4-ADA5-E607521249DE Q22242610-A34ED0BF-E3C5-4FDA-822F-9C6520A4ADF9 Q24293721-DCA7B82B-1020-404B-9033-2EFD8C19223C Q24307370-3592EE42-EA95-411C-8CEE-3DE1F54D86D3 Q24338569-993F670E-357F-4CAC-92AF-E6D988C8C5EA Q24338707-168AA7D5-41D6-4B93-85D7-AC0D4CB22D23 Q24339520-454DCA3F-8466-460F-B3E5-632FE3F563A7 Q24620825-8D58C7FE-D2A8-493F-967D-961A79004021 Q26741938-9F6A4BAB-C21A-49CF-8572-CFA0249C64E8 Q26746703-B03AFD9C-3D47-461F-8F92-EADC1F530024 Q26770764-5F2D49E8-B383-4D01-830B-A45EC9C90D6D Q26775413-FEF0E61E-E1DD-4835-A487-2A8F826908F9 Q26778780-DB9D3823-A8CD-41AF-8F3D-B9D52E2D501A Q26795760-C360D27C-753C-443F-B652-1728A7EC72B7 Q26798010-5403EF1B-BD92-4701-92E7-594C16215D45 Q26799953-F11CFEE0-4B1B-4217-8829-8C09EE9B48B6 Q26821792-AD19D86B-B855-4D7A-924B-0496D5BF31A9 Q26824575-AF577695-28AC-457C-AA5E-553BD34D1336 Q26828610-29A0DB72-DFF2-4BAD-BAA7-2127C4EEC922 Q26829218-ECBA3F3E-57C6-41DD-B3B0-B15732766DCB Q26852087-073DF765-6A65-465A-98C7-C6AA417177F8 Q26852288-03879659-8DFA-4FF3-9742-A55C48D2DCD3 Q26861785-CE6D8067-C983-4AC5-B355-7C094CF9CAF0 Q26863394-0571B89A-1FDD-4C80-BA0E-008E54F5C807 Q26991867-EF209126-89F1-4385-80AF-7F0D9CCEE1F6 Q26994739-6938FF91-FD87-4442-BC4A-9884DB7DF934 Q27007679-A0FF57E0-DBCA-42E9-878B-2901F0A67319 Q27010637-80D9742D-3338-480B-AD76-488B4AFA735D Q27027763-CC2AF557-A35F-41F4-9719-0978C9FA563B Q27349142-EBC4BA35-5DD0-4235-AFEE-C687AF7BD755 Q27675100-14125C66-AFAF-45B6-870A-44266B46BEF8 Q27675574-0F7F3550-3839-4DC5-8FD4-15A1EF1D2757 Q27683539-C62243FF-05E4-4C5D-8CF8-C59580512C85 Q27684229-A464511D-723E-45FE-8712-5EF4E620E297 Q27704244-6AB8FB6E-FF43-4C24-9F6F-DD1CA5780B6D Q27929810-F2206EC6-2E6A-410D-B9CA-0E4980730963 Q28076257-B3B0DEFD-E2A7-48AA-8308-AA13BA449EC2 Q28083849-A7A9D911-A283-489E-B5C8-66CC33DA4E40 Q28085672-231D9B74-5BD4-400A-A001-FB6F7E515AE2 Q28257534-E86507A0-7A79-443D-9C1F-FD8D2C81BF06

P2860

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

http://www.wikidata.org/entity/Q24605342

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Covalent histone modifications ...... nd mis-erased in human cancers

@ast

Covalent histone modifications ...... nd mis-erased in human cancers

@en

Covalent histone modifications ...... nd mis-erased in human cancers

@nl

type

label

Covalent histone modifications ...... nd mis-erased in human cancers

@ast

Covalent histone modifications ...... nd mis-erased in human cancers

@en

Covalent histone modifications ...... nd mis-erased in human cancers

@nl

prefLabel

Covalent histone modifications ...... nd mis-erased in human cancers

@ast

Covalent histone modifications ...... nd mis-erased in human cancers

@en

Covalent histone modifications ...... nd mis-erased in human cancers

@nl

P1433

Q24605342-4AE7D86E-633B-43A2-AC46-71B54C7D794B

P1476

Q24605342-47517556-7571-488F-B39A-7568CA25FD70

P2093

Q24605342-12E2C088-8051-4660-ADA8-BC24C6B73C06

Q24605342-6CD7C669-38D8-454D-8D4B-1E9B98DA8702

P2860

Q24605342-01462D88-D0A0-46B6-AFF2-9BD569267E1A

Q24605342-03430999-ED72-4A8D-B909-9C32032C27E2

Q24605342-085A63D9-5240-42A3-9B08-54A3C0B7B471

Q24605342-08F074B6-ECDF-435D-96BB-7D4E401D3C73

Q24605342-0A09630D-01E9-48A5-B2B2-91E3875F402B

Q24605342-0B21D535-0CB1-4F55-9A69-1CA61C760066

Q24605342-11165959-2866-49BC-A2F8-39132C31933F

Q24605342-17B6576B-4A25-49FC-ACDF-534CDF8DDF53

Q24605342-1989AADF-BB79-41B2-9346-F4585829B8F9

Q24605342-1B228A4F-6E3D-4824-9A29-59AF44810257

P2888

Q24605342-A16CC947-9807-48D7-B99D-7E87D8725D35

P304

Q24605342-EFD4D051-E2C7-47ED-952D-DF889401CBB8

P31

Q24605342-43108D70-F389-45FF-A447-3CA8BEFF2E21

P3181

Q24605342-41A2C394-BFCA-4180-B68D-96792D236063

P356

Q24605342-F32256A0-1159-43AA-B44C-101877886AFC

P407

Q24605342-F0EE5402-AB61-49A2-BED3-864D7F7E02F6

P433

Q24605342-1339C4AA-A89C-4002-9F1C-C2D0724F2A8C

P478

Q24605342-CAEA0A89-D63A-4DDC-BB18-0D05286453B2

P50

Q24605342-99597062-39CA-4C76-80AD-D04D43C141D1

P577

Q24605342-67D977D5-1085-48E7-B82E-C1D93E38F966

P5875

Q24605342-F0CE8CC7-C84A-423B-B22A-5D330BFF654F

P6179

Q24605342-9BD8A79C-29EB-4613-A9D2-6063B488DD86

P698

Q24605342-7DB1021C-F411-4F3E-9756-9F226289E8D2

P932

Q24605342-20E0CAC4-793D-4CBE-8916-D146F0D1E5B0

P3181

P356

P1433

Nature Reviews Cancer

P1476

Covalent histone modifications ...... nd mis-erased in human cancers

@en

P2093

C David Allis

http://www.w3.org/2001/XMLSchema#string

Ping Chi

http://www.w3.org/2001/XMLSchema#string

P2860

Translating the Histone Code

p53 is regulated by the lysine demethylase LSD1

Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex

Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4

ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation

Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)

JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity

Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex

Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation

P2888

P304

457-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

246152

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRC2876

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44698640

http://www.w3.org/2001/XMLSchema#string

P6179

1013013054

http://www.w3.org/2001/XMLSchema#string

P698

20574448

http://www.w3.org/2001/XMLSchema#string

P932

3262678

http://www.w3.org/2001/XMLSchema#string